Being Patient talks to Dr. Rudi Tanzi, Professor of Neurology at Harvard University, about the latest developments in the research on Alzheimer’s disease and why the FDA needs to lower the bar on Alzheimer’s drug testing.
Being Patient talks to Dr. Rudi Tanzi, Professor of Neurology at Harvard University, about the latest developments in the research on Alzheimer’s disease and why the FDA needs to lower the bar on Alzheimer’s drug testing.
